Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
nanoliposomes with cholesterol and lipid extract
- Development stage
- Preclinical
- Lead developer
- Massachusetts College of Pharmacy and Health Sciences
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
Nanoliposomes with cholesterol and lipid extract are an experimental biomimetic drug delivery system under investigation for the treatment of low-grade serous ovarian carcinoma (LGSOC). Developed by researchers at the Massachusetts College of Pharmacy and Health Sciences, these nanoliposomes are composed of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), cholesterol, and a cellular lipid extract (LE) derived from LGSOC cell lines (e.g., PM-LGSOC-01). The formulation strategy aims to enhance target specificity and cellular internalization by mimicking the lipid profile of the tumor cells. Preclinical studies presented at AACR 2026 indicate that optimizing the cholesterol concentration is critical for maximizing cellular uptake, potentially offering a more effective delivery mechanism for therapeutic agents in chemotherapy-resistant LGSOC.
- Other names
- DOPC/Chol/LE nanoliposomesPM-LGSOC-01-lipid extract nanoliposomesPM-LGSOC01-lipid extract nanoliposomesPM-LGSOC 01-lipid extract nanoliposomes
Beyond the preview
Go deeper on nanoliposomes with cholesterol and lipid extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on nanoliposomes with cholesterol and lipid extract.